ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 983,64
0,13%
Dow Jones
44 384,46
0,18%
DAX
21 889,58
0,58%
Brent Oil
75,345
0,97%
Bitcoin
97 480,34
1,02%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NYSE
  6. Enovis Corporation (ENOV)

  7. Enovis Corporation (ENOV) Actualités

ENOV

Enovis (ENOV)

Enovis Corporation
De:
Trier par:
 Showing the most relevant articles for your search:NYSE:ENOV
DateHeureSourceTitreSymboleSociété
29/01/202513h00GlobeNewswire Inc.Enovis to Host Fourth Quarter and Full Year 2024 Results Conference Call on February 26thNYSE:ENOVEnovis Corporation
28/01/202513h17Edgar (US Regulatory)Form 8-K - Current reportNYSE:ENOVEnovis Corporation
28/01/202512h51Edgar (US Regulatory)Form 424B7 - Prospectus [Rule 424(b)(7)]NYSE:ENOVEnovis Corporation
17/01/202512h00GlobeNewswire Inc.Enovis™ Announces Leadership Change to International Surgical BusinessNYSE:ENOVEnovis Corporation
08/01/202500h19PR Newswire (US)Maplebear Set to Join S&P MidCap 400; Enovis to Join S&P SmallCap 600NYSE:ENOVEnovis Corporation
06/01/202522h15GlobeNewswire Inc.Enovis to Participate in the 43rd Annual J.P. Morgan Healthcare ConferenceNYSE:ENOVEnovis Corporation
18/11/202422h10GlobeNewswire Inc.Enovis to Participate in Upcoming Investor ConferencesNYSE:ENOVEnovis Corporation
14/11/202419h28Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NYSE:ENOVEnovis Corporation
06/11/202422h12Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NYSE:ENOVEnovis Corporation
06/11/202412h00GlobeNewswire Inc.Enovis Announces Third Quarter 2024 ResultsNYSE:ENOVEnovis Corporation
10/10/202413h00GlobeNewswire Inc.Enovis to Host Third Quarter 2024 Results Conference Call on November 6thNYSE:ENOVEnovis Corporation
09/09/202421h50GlobeNewswire Inc.Enovis Appoints Tim Czartoski as President, U.S. Surgical and Global Product and Enabling TechnologiesNYSE:ENOVEnovis Corporation
05/09/202414h00GlobeNewswire Inc.Enovis™ Introduces the Next Generation of Foot and Ankle Surgery Offerings at AOFAS Annual MeetingNYSE:ENOVEnovis Corporation
20/08/202414h00GlobeNewswire Inc.Enovis Continues to Redefine Revision Knee Surgery with the Addition of EMPOWR™ Cones to EMPOWR Revision Knee™, Creating a Comprehensive Portfolio for Efficient Revision ProceduresNYSE:ENOVEnovis Corporation
19/08/202414h00GlobeNewswire Inc.Enovis™ Introduces STAR® Ankle, now with e+™ Polyethylene for Unmatched DurabilityNYSE:ENOVEnovis Corporation
08/08/202402h00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:ENOVEnovis Corporation
07/08/202412h00GlobeNewswire Inc.Enovis Announces Second Quarter 2024 ResultsNYSE:ENOVEnovis Corporation
25/07/202412h00GlobeNewswire Inc.Enovis Announces Time Change for Second Quarter 2024 Results Conference CallNYSE:ENOVEnovis Corporation
16/07/202413h00GlobeNewswire Inc.Enovis to Host Second Quarter 2024 Results Conference Call on August 7thNYSE:ENOVEnovis Corporation
12/07/202414h00GlobeNewswire Inc.Enovis™ Releases AltiVate Reverse® Glenoid System, Widening Range of Patients Who May be Treated with AltiVate Reverse®NYSE:ENOVEnovis Corporation
31/05/202422h05Edgar (US Regulatory)Form SD - Specialized disclosure reportNYSE:ENOVEnovis Corporation
02/05/202412h00GlobeNewswire Inc.Enovis Announces First Quarter 2024 ResultsNYSE:ENOVEnovis Corporation
17/04/202413h00GlobeNewswire Inc.Enovis to Host First Quarter 2024 Results Conference Call on May 2ndNYSE:ENOVEnovis Corporation
28/03/202412h00GlobeNewswire Inc.Enovis to Participate in the 23rd Annual Needham Virtual Healthcare ConferenceNYSE:ENOVEnovis Corporation
22/02/202412h57Edgar (US Regulatory)Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuersNYSE:ENOVEnovis Corporation
22/02/202412h22Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NYSE:ENOVEnovis Corporation
22/02/202412h00GlobeNewswire Inc.Enovis Announces Fourth Quarter and Full Year 2023 ResultsNYSE:ENOVEnovis Corporation
21/02/202422h48Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NYSE:ENOVEnovis Corporation
14/02/202416h04Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NYSE:ENOVEnovis Corporation
12/02/202417h30GlobeNewswire Inc.Enovis™ to Highlight Latest Technologies Across the Orthopedic Care Continuum at 2024 AAOS Annual MeetingNYSE:ENOVEnovis Corporation
 Showing the most relevant articles for your search:NYSE:ENOV

Dernières Valeurs Consultées

COIN
AVAXUSD
Avalanche
EU
AF
Air FranceKLM
EU
VIV
Vivendi
EU
AI
Air Liquide
SPI
SP500
S&P 500
EU
VK
Vallourec
EU
RNO
Renault
EU
HO
Thales
NYSE
KO
Coca Cola
NYSE
MRK
Merck
EU
CS
Axa
FTSE
UKX
FTSE 100
EU
PX1
CAC 40
EU
ACA
Credit Agricole
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2025 ADVFN PLC - Tous droits réservés

Supprimer les publicités

Inscrivez-vous pour une expérience sans publicité

Aucune publicité

Essayez maintenant

Conserver les annonces